{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:13:23Z","timestamp":1762884803155,"version":"3.45.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["R01MD012421","R01MD012421","R01MD012421","R01MD012421"],"award-info":[{"award-number":["R01MD012421","R01MD012421","R01MD012421","R01MD012421"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with HIV (PWH) from racial and ethnic minority groups in the United States (US) face a high risk for severe COVID-19 outcomes and have low uptake of the COVID-19 vaccine primary series and booster doses. This study aims to provide insights into barriers and facilitators to vaccination and identify strategies to increase vaccine trust and uptake in these populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between November and December 2022, we conducted qualitative interviews with 24 vaccinated and unvaccinated adult PWH who self-identified as Hispanic\/Latinx, Black\/African American, or Haitian, and were clients of the Miami-Dade County Ryan White HIV\/AIDS Program in Florida, US. Data were analyzed using deductive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Main barriers to vaccine uptake reported by participants included low or no perception of COVID-19 risk, concerns about safety and efficacy related to HIV status, mistrust of COVID-19 vaccines, general vaccine hesitancy, negative experiences and advice against vaccination within social networks, lack of provider recommendation, and exposure to negative messaging and misinformation about vaccines. Facilitators included perceived risk, awareness of the vaccines\u2019 protective benefits for HIV-immunocompromised individuals and reducing transmission, encouragement and role modeling within social networks, provider recommendation, and exposure to accurate information from reputable sources. Some recommended strategies to increase uptake and trust in vaccines included incorporating vaccination into routine HIV care, leveraging peers with HIV, tailoring vaccine information and messaging, and partnering with trusted individuals for outreach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Vaccination efforts for PWH should prioritize addressing specific barriers and concerns related to their HIV status and tailoring strategies to meet their needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-25017-9","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:31:47Z","timestamp":1762781507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers to COVID-19 vaccination and strategies to increase trust and uptake among racial and ethnic minorities with HIV in South Florida: a qualitative study"],"prefix":"10.1186","volume":"25","author":[{"given":"Daisy","family":"Ram\u00edrez-Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Moise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Yasaman","family":"Alemohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariolga","family":"Aymat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaliyah","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Jean-Gilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ladner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jo","family":"Trepka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"25017_CR1","doi-asserted-by":"publisher","first-page":"873596","DOI":"10.3389\/fpubh.2022.873596","volume":"10","author":"K Rahmani","year":"2022","unstructured":"Rahmani K, Shavaleh R, Forouhi M, Disfani HF, Kamandi M, Oskooi RK, et al. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis. Front Public Health. 2022;10:873596.","journal-title":"Front Public Health"},{"key":"25017_CR2","unstructured":"WHO, Tracking. SARS-CoV-2 variants 2024: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants"},{"issue":"10","key":"25017_CR3","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3201\/eid2810.221058","volume":"28","author":"AC Keyel","year":"2022","unstructured":"Keyel AC, Russell A, Plitnick J, Rowlands JV, Lamson DM, Rosenberg E, et al. SARS-CoV-2 vaccine breakthrough by Omicron and delta variants, new York, USA. Emerg Infect Dis. 2022;28(10):1990\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"25017_CR4","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.1016\/S2352-3018(22)00097-2","volume":"9","author":"S Bertagnolio","year":"2022","unstructured":"Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, et al. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO global clinical platform of COVID-19. Lancet HIV. 2022;9(7):e486\u201395.","journal-title":"Lancet HIV"},{"issue":"7","key":"25017_CR5","doi-asserted-by":"publisher","first-page":"e2005","DOI":"10.1093\/cid\/ciaa1198","volume":"73","author":"Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases South Africa","year":"2021","unstructured":"Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases South Africa. Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western cape Province, South Africa. Clin Infect Dis. 2021;73(7):e2005\u201315.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"25017_CR6","doi-asserted-by":"publisher","first-page":"e2095","DOI":"10.1093\/cid\/ciaa1605","volume":"73","author":"AM Geretti","year":"2021","unstructured":"Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, et al. Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC world health organization (WHO) clinical characterization protocol (UK): A prospective observational study. Clin Infect Dis. 2021;73(7):e2095\u2013106.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"25017_CR7","doi-asserted-by":"publisher","first-page":"e2037069","DOI":"10.1001\/jamanetworkopen.2020.37069","volume":"4","author":"JM Tesoriero","year":"2021","unstructured":"Tesoriero JM, Swain CE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in new York state. JAMA Netw Open. 2021;4(2):e2037069.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"25017_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/cid\/ciad084","volume":"76","author":"AN Lea","year":"2023","unstructured":"Lea AN, Leyden WA, Sofrygin O, Marafino BJ, Skarbinski J, Napravnik S, et al. Human immunodeficiency virus status, Tenofovir exposure, and the risk of poor coronavirus disease 19 outcomes: real-world analysis from 6 united States cohorts before vaccine rollout. Clin Infect Dis. 2023;76(10):1727\u201334.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"25017_CR9","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/infdis\/jiad311","volume":"228","author":"SL Braunstein","year":"2023","unstructured":"Braunstein SL, Wahnich A, Lazar R. COVID-19 outcomes among people with HIV and COVID-19 in new York City. J Infect Dis. 2023;228(11):1571\u201382.","journal-title":"J Infect Dis"},{"issue":"7","key":"25017_CR10","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1093\/cid\/ciaa1339","volume":"73","author":"D Dandachi","year":"2021","unstructured":"Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clin Infect Dis. 2021;73(7):e1964\u201372.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"25017_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/hiv.13037","volume":"22","author":"C Hoffmann","year":"2021","unstructured":"Hoffmann C, Casado JL, H\u00e4rter G, Vizcarra P, Moreno A, Cattaneo D, et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021;22(5):372\u20138.","journal-title":"HIV Med"},{"issue":"6","key":"25017_CR12","doi-asserted-by":"publisher","first-page":"e2215934","DOI":"10.1001\/jamanetworkopen.2022.15934","volume":"5","author":"SB Coburn","year":"2022","unstructured":"Coburn SB, Humes E, Lang R, Stewart C, Hogan BC, Gebo KA, et al. Analysis of postvaccination breakthrough COVID-19 infections among adults with HIV in the united States. JAMA Netw Open. 2022;5(6):e2215934.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"25017_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jamainternmed.2021.7024","volume":"182","author":"J Sun","year":"2022","unstructured":"Sun J, Zheng Q, Madhira V, Olex AL, Anzalone AJ, Vinson A, et al. Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US. JAMA Intern Med. 2022;182(2):153\u201362.","journal-title":"JAMA Intern Med"},{"key":"25017_CR14","doi-asserted-by":"crossref","unstructured":"Soyer EM, McGinnis KA, Justice AC, Hsieh E, Rodriguez-Barradas MC, Williams EC et al. COVID-19 breakthrough infection after vaccination and substance use disorders: a longitudinal cohort of people with and without HIV receiving care in the united States veterans health administration. AIDS Behav. 2024;28(11):3605\u20133614.","DOI":"10.1007\/s10461-024-04449-1"},{"key":"25017_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijid.2023.11.029","volume":"139","author":"X Yang","year":"2024","unstructured":"Yang X, Zhang J, Liu Z, Chen S, Olatosi B, Poland GA, et al. COVID-19 breakthrough infections among people living with and without HIV: A statewide cohort analysis. Int J Infect Dis. 2024;139:21\u20137.","journal-title":"Int J Infect Dis"},{"issue":"12","key":"25017_CR16","doi-asserted-by":"publisher","first-page":"e1021","DOI":"10.1093\/cid\/ciaa1793","volume":"72","author":"SL Braunstein","year":"2021","unstructured":"Braunstein SL, Lazar R, Wahnich A, Daskalakis DC, Blackstock OJ. Coronavirus disease 2019 (COVID-19) infection among people with human immunodeficiency virus in new York city: a population-level analysis of linked surveillance sata. Clin Infect Dis. 2021;72(12):e1021\u20139.","journal-title":"Clin Infect Dis"},{"key":"25017_CR17","unstructured":"CDC. Vaccines for moderately to severely immunocompromised people 2024: https:\/\/www.cdc.gov\/covid\/vaccines\/immunocompromised-people.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/immuno.html"},{"issue":"7","key":"25017_CR18","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1007\/s10461-021-03570-9","volume":"26","author":"TW Menza","year":"2022","unstructured":"Menza TW, Capizzi J, Zlot AI, Barber M, Bush L. COVID-19 vaccine uptake among people living with HIV. AIDS Behav. 2022;26(7):2224\u20138.","journal-title":"AIDS Behav"},{"issue":"6","key":"25017_CR19","doi-asserted-by":"publisher","first-page":"e2415220","DOI":"10.1001\/jamanetworkopen.2024.15220","volume":"7","author":"RC Hechter","year":"2024","unstructured":"Hechter RC, Qian L, Liu IA, Sy LS, Ryan DS, Xu S, et al. COVID-19 vaccination coverage and factors associated with vaccine uptake among people with HIV. JAMA Netw Open. 2024;7(6):e2415220.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"25017_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/QAI.0000000000003177","volume":"93","author":"EM Rosenthal","year":"2023","unstructured":"Rosenthal EM, Patterson W, Chicoine J, Dorabawila V, Adamashvili N, Rajulu DT, et al. COVID-19 vaccination and hospitalization among persons living with diagnosed HIV in new York state. J Acquir Immune Defic Syndr. 2023;93(2):92\u2013100.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"25017_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/QAI.0000000000003369","volume":"95","author":"D Ram\u00edrez-Ortiz","year":"2024","unstructured":"Ram\u00edrez-Ortiz D, Jean-Gilles M, Sheehan DM, Ladner R, Li T, Trepka MJ. Factors associated with COVID-19 vaccination among racial\/ethnic minority groups with HIV in South Florida. J Acquir Immune Defic Syndr. 2024;95(4):329\u201341.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"25017_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/apc.2021.0144","volume":"36","author":"J Jaiswal","year":"2022","unstructured":"Jaiswal J, Krause KD, Martino RJ, D\u2019Avanzo PA, Griffin M, Stults CB, et al. SARS-CoV-2 vaccination hesitancy and behaviors in a National sample of people living with HIV. AIDS Patient Care STDS. 2022;36(1):34\u201344.","journal-title":"AIDS Patient Care STDS"},{"key":"25017_CR23","doi-asserted-by":"crossref","unstructured":"Gray A, Alemohammad SY, Ram\u00edrez-Ortiz D, Trepka MJ. A systematic review of factors associated with COVID-19 vaccine uptake, hesitancy, and acceptability among adults with HIV: implications for integrating COVID-19 immunization into HIV care. AIDS Patient Care STDS. 2024:1\u201335.","DOI":"10.1089\/apc.2024.0097"},{"key":"25017_CR24","unstructured":"FDOH. Patient care-eligibility information 2023 [cited 2023 April 12]. Available from: https:\/\/www.floridahealth.gov\/diseases-and-conditions\/aids\/patient-care\/eligibility-information1.html"},{"issue":"2","key":"25017_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/109019818801500203","volume":"15","author":"IM Rosenstock","year":"1988","unstructured":"Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175\u201383.","journal-title":"Health Educ Q"},{"issue":"4","key":"25017_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/109019818801500401","volume":"15","author":"KR McLeroy","year":"1988","unstructured":"McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15(4):351\u201377.","journal-title":"Health Educ Q"},{"key":"25017_CR27","unstructured":"Lumivero. NVivo Transcription 2024 [Available from: https:\/\/lumivero.com\/products\/nvivo-transcription\/"},{"key":"25017_CR28","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Thematic analysis: American Psychological Association; 2012.","DOI":"10.1037\/13620-004"},{"key":"25017_CR29","unstructured":"Lumivero. NVivo Version 14 2024: https:\/\/lumivero.com\/buy-now\/nvivo-getting-started-bundle\/"},{"issue":"8","key":"25017_CR30","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.3390\/ijerph19084649","volume":"19","author":"S Cipolletta","year":"2022","unstructured":"Cipolletta S, Andreghetti GR, Mioni G. Risk perception towards COVID-19: a systematic review and qualitative synthesis. Int J Environ Res Public Health. 2022;19(8):4649.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"25017_CR31","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1186\/s12889-022-14563-1","volume":"22","author":"AL Lohiniva","year":"2022","unstructured":"Lohiniva AL, Pensola A, Hy\u00f6kki S, Sivel\u00e4 J, Tammi T. COVID-19 risk perception framework of the public: an infodemic tool for future pandemics and epidemics. BMC Public Health. 2022;22(1):2124.","journal-title":"BMC Public Health"},{"issue":"1","key":"25017_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/acp.3894","volume":"36","author":"AM Weil","year":"2022","unstructured":"Weil AM, Wolfe CR. Individual differences in risk perception and misperception of COVID-19 in the context of political ideology. Appl Cogn Psychol. 2022;36(1):19\u201331.","journal-title":"Appl Cogn Psychol"},{"issue":"1","key":"25017_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/5901128","volume":"2023","author":"D Storer","year":"2023","unstructured":"Storer D, Lafferty L, Graham S, Murphy D, Rance J, Brener L, et al. Perceptions of COVID-19 vaccines: lessons from selected populations who experience discrimination in the Australian healthcare system. Health Soc Care Community. 2023;2023(1):1\u201310.","journal-title":"Health Soc Care Community"},{"issue":"1","key":"25017_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12889-024-18020-z","volume":"24","author":"J Waterschoot","year":"2024","unstructured":"Waterschoot J, Vansteenkiste M, Yzerbyt V, Morb\u00e9e S, Klein O, Luminet O, et al. Risk perception as a motivational resource during the COVID-19 pandemic: the role of vaccination status and emerging variants. BMC Public Health. 2024;24(1):731.","journal-title":"BMC Public Health"},{"issue":"6","key":"25017_CR35","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1007\/s10903-023-01513-1","volume":"25","author":"C Kirchoff","year":"2023","unstructured":"Kirchoff C, Penn A, Wang W, Babino R, De La Rosa M, Cano MA, et al. COVID-19 vaccine acceptance among Latino\/a immigrants: the role of collective responsibility and confidence. J Immigr Minor Health. 2023;25(6):1246\u201353.","journal-title":"J Immigr Minor Health"},{"issue":"1","key":"25017_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41562-023-01733-3","volume":"8","author":"SK Sulaiman","year":"2024","unstructured":"Sulaiman SK, Musa MS, Tsiga-Ahmed FI, Sulaiman AK, Bako AT. A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV. Nat Hum Behav. 2024;8(1):100\u201314.","journal-title":"Nat Hum Behav"},{"issue":"8","key":"25017_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/tmi.13908","volume":"28","author":"JY Ejamo","year":"2023","unstructured":"Ejamo JY, Legese GL, Tesfaye YA, Liben FE. COVID-19 vaccine acceptance among people living with HIV: A systematic review and meta-analysis. Trop Med Int Health. 2023;28(8):601\u201311.","journal-title":"Trop Med Int Health"},{"issue":"5","key":"25017_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"issue":"27","key":"25017_CR39","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"23","key":"25017_CR40","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, C\u00e1rdenas V, Shukarev G, Grinsztejn B, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19. N Engl J Med. 2021;384(23):2187\u2013201.","journal-title":"N Engl J Med"},{"issue":"6","key":"25017_CR41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/NEJMoa2116185","volume":"386","author":"LM Dunkle","year":"2022","unstructured":"Dunkle LM, Kotloff KL, Gay CL, \u00c1\u00f1ez G, Adelglass JM, Barrat Hern\u00e1ndez AQ, et al. Efficacy and safety of NVX-CoV2373 in adults in the united States and Mexico. N Engl J Med. 2022;386(6):531\u201343.","journal-title":"N Engl J Med"},{"issue":"12","key":"25017_CR42","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.cmi.2021.07.031","volume":"27","author":"I Levy","year":"2021","unstructured":"Levy I, Wieder-Finesod A, Litchevsky V, Biber A, Indenbaum V, Olmer L, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin Microbiol Infect. 2021;27(12):1851\u20135.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"25017_CR43","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2352-3018(21)00103-X","volume":"8","author":"J Frater","year":"2021","unstructured":"Frater J, Ewer KJ, Ogbe A, Pace M, Adele S, Adland E, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2\/3 clinical trial. Lancet HIV. 2021;8(8):e474\u201385.","journal-title":"Lancet HIV"},{"issue":"9","key":"25017_CR44","first-page":"1","volume":"10","author":"L Kang","year":"2022","unstructured":"Kang L, Shang W, Gao P, Wang Y, Liu J, Liu M. Immunogenicity and safety of COVID-19 vaccines among people living with HIV: a systematic review and meta-analysis. Vaccines (Basel). 2022;10(9):1\u201315.","journal-title":"Vaccines (Basel)"},{"key":"25017_CR45","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1017\/S095026882300153X","volume":"151","author":"T Zhao","year":"2023","unstructured":"Zhao T, Yang Z, Wu Y, Yang J. Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis. Epidemiol Infect. 2023;151:e176.","journal-title":"Epidemiol Infect"},{"issue":"28","key":"25017_CR46","doi-asserted-by":"publisher","first-page":"899","DOI":"10.15585\/mmwr.mm7128a3","volume":"71","author":"AM Hause","year":"2022","unstructured":"Hause AM, Baggs J, Marquez P, Abara WE, Baumblatt JG, Thompson D, et al. Safety monitoring of COVID-19 mRNA vaccine first booster doses among persons Aged\u2009\u2265\u200912 years with presumed Immunocompromise status - United States, January 12, 2022-March 28, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(28):899\u2013903.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"25017_CR47","doi-asserted-by":"publisher","first-page":"102300","DOI":"10.1016\/j.pmedr.2023.102300","volume":"35","author":"M Javanbakht","year":"2023","unstructured":"Javanbakht M, Khan L, Mustanski B, Shoptaw S, Baum MK, Mehta SH, et al. Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: findings from the C3PNO consortium. Prev Med Rep. 2023;35:102300.","journal-title":"Prev Med Rep"},{"key":"25017_CR48","unstructured":"CDC. Recommended adult immunization schedule for ages 19 years or older 2024: https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/adult\/adult-combined-schedule.pdf"},{"key":"25017_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijid.2022.10.005","volume":"124","author":"J Yin","year":"2022","unstructured":"Yin J, Chen Y, Li Y, Wang C, Zhang X. Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis. Int J Infect Dis. 2022;124:212\u201323.","journal-title":"Int J Infect Dis"},{"key":"25017_CR50","unstructured":"NIH. COVID-19 vaccination communication: applying behavioral and social science to address vaccine hesitancy and foster vaccine confidence 2020: https:\/\/www.obssr.od.nih.gov\/sites\/obssr\/files\/inline-files\/OBSSR_VaccineWhitePaper_FINAL_508.pdf"},{"issue":"2","key":"25017_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/QAI.0000000000002570","volume":"86","author":"LM Bogart","year":"2021","unstructured":"Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, et al. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among black Americans living with HIV. J Acquir Immune Defic Syndr. 2021;86(2):200\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"25017_CR52","unstructured":"Quinn S, Jamison A, Musa D, Hilyard K, Freimuth V. Exploring the continuum of vaccine hesitancy between African American and white adults: results of a qualitative study. PLoS Curr. 2016;8: ecurrents.outbreaks.3e4a5ea39d8620494e2a2c874a3c4201."},{"key":"25017_CR53","doi-asserted-by":"publisher","first-page":"113684","DOI":"10.1016\/j.socscimed.2021.113684","volume":"270","author":"CA Latkin","year":"2021","unstructured":"Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B. Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med. 2021;270:113684.","journal-title":"Soc Sci Med"},{"key":"25017_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2022.100213","volume":"12","author":"B Adhikari","year":"2022","unstructured":"Adhikari B, Yeong Cheah P, von Seidlein L. Trust is the common denominator for COVID-19 vaccine acceptance: a literature review. Vaccine X. 2022;12:100213.","journal-title":"Vaccine X"},{"issue":"9","key":"25017_CR55","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.27582","volume":"4","author":"SL Carson","year":"2021","unstructured":"Carson SL, Casillas A, Castellon-Lopez Y, Mansfield LN, Morris D, Barron J, et al. COVID-19 vaccine decision-making factors in racial and ethnic minority communities in Los Angeles, California. JAMA Netw Open. 2021;4(9):e2127582.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"25017_CR56","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1007\/s10461-020-02925-y","volume":"24","author":"J Jaiswal","year":"2020","unstructured":"Jaiswal J, LoSchiavo C, Perlman DC. Disinformation, misinformation and inequality-driven mistrust in the time of COVID-19: lessons unlearned from AIDS denialism. AIDS Behav. 2020;24(10):2776\u201380.","journal-title":"AIDS Behav"},{"issue":"1","key":"25017_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/07395329221095850","volume":"44","author":"H Schmidt","year":"2023","unstructured":"Schmidt H. Pandemics and politics: analyzing the politicization and polarization of pandemic-related reporting. Newsp Res J. 2023;44(1):26\u201352.","journal-title":"Newsp Res J"},{"key":"25017_CR58","unstructured":"CDC. 12 COVID-19 vaccination strategies for your community 2022 [Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/vaccinate-with-confidence\/community.html"},{"issue":"5","key":"25017_CR59","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1056\/NEJMpv2035827","volume":"384","author":"S Bajaj","year":"2021","unstructured":"Bajaj S, Stanford F. Beyond Tuskegee - vaccine distrust and everyday racism. N Engl J Med. 2021;384(5):e12.","journal-title":"N Engl J Med"},{"issue":"4","key":"25017_CR60","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7326\/M20-6141","volume":"174","author":"M Alsan","year":"2021","unstructured":"Alsan M, Stanford FC, Banerjee A, Breza E, Chandrasekhar AG, Eichmeyer S, et al. Comparison of knowledge and information-seeking behavior after general COVID-19 public health messages and messages tailored for Black and Latinx communities: a randomized controlled trial. Ann Intern Med. 2021;174(4):484\u201392.","journal-title":"Ann Intern Med"},{"issue":"11","key":"25017_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111685","volume":"11","author":"PE Cummings","year":"2023","unstructured":"Cummings PE, Lakoh S, Yendewa SA, Massaquoi SPE, James PB, Sahr F, et al. Understanding COVID-19 vaccine uptake and hesitancy among people with HIV in Freetown, Sierra Leone: a cross-sectional study. Vaccines. 2023;11(11):1685.","journal-title":"Vaccines"},{"issue":"2","key":"25017_CR62","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/1532673X221148670","volume":"51","author":"S Amlani","year":"2023","unstructured":"Amlani S, Kiesel S, Butters R. Polarization in COVID-19 vaccine discussion networks. Am Polit Res. 2023;51(2):260\u201373.","journal-title":"Am Polit Res"},{"issue":"9","key":"25017_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-006237","volume":"6","author":"MDC Re\u00f1osa","year":"2021","unstructured":"Re\u00f1osa MDC, Landicho J, Wachinger J, Dalglish SL, B\u00e4rnighausen K, B\u00e4rnighausen T, et al. Nudging toward vaccination: a systematic review. BMJ Glob Health. 2021;6(9):e006237.","journal-title":"BMJ Glob Health"},{"issue":"11","key":"25017_CR64","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1037\/hea0001400","volume":"43","author":"J Zhang","year":"2024","unstructured":"Zhang J, Jin H. Interventions involving nudge theory for COVID-19 vaccination: a systematic review and meta-analysis. Health Psychol. 2024;43(11):779\u201390.","journal-title":"Health Psychol"},{"key":"25017_CR65","unstructured":"WHO. Considerations for integrating COVID-19 vaccination into immunization programmes and primary health care for 2022 and beyond 2023 [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240064454"},{"issue":"4","key":"25017_CR66","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1077558712465774","volume":"70","author":"C Rathert","year":"2013","unstructured":"Rathert C, Wyrwich MD, Boren SA. Patient-centered care and outcomes: a systematic review of the literature. Med Care Res Rev. 2013;70(4):351\u201379.","journal-title":"Med Care Res Rev"},{"issue":"5","key":"25017_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.14229","volume":"59","author":"M Knox","year":"2023","unstructured":"Knox M, Hernandez EA, Brown DM, Ahern J, Fleming MD, Guo C, et al. Greater COVID-19 vaccine uptake among enrollees offered health and social needs case management: results from a randomized trial. Health Serv Res. 2023;59(5):e14229.","journal-title":"Health Serv Res"},{"key":"25017_CR68","unstructured":"WHO, Tackling. COVID-19 misinformation a social media toolkit for healthcare practitioners 2021: https:\/\/www.who.int\/publications\/m\/item\/a-social-media-toolkit-for-healthcare-practitioners---desktop"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25017-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:10:01Z","timestamp":1762884601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-25017-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25017"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25017-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This qualitative study was approved by the Florida International University Social and Behavioral Institutional Review Board (IRB study # 105954), which was established under United States federal regulations for the protection of human subjects in research (45 CFR 46). This study was conducted in accordance with the approved protocol, and verbal informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3885"}}